MSF Field Research > 1 Published Research and Commentary > HIV/AIDS > Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/120329
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
101119_Pujades_ART-Cambodia-outcomes-resist_TMIH-2011-16-205-13.pdfMain article160KbAdobe PDF

Title: Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia
Authors: Pujades-Rodríguez, Mar
Schramm, Birgit
Som, Leakena
Nerrienet, Eric
Narom, Prak
Chanchhaya, Ngeth
Ferradini, Laurent
Balkan, Suna
Affiliation: Epicentre, Paris, France; Medecins Sans Frontieres, Phnom Penh, Cambodia; HIV⁄Hepatitis Laboratory, Pasteur Institute, Phnom Penh, Cambodia; Khmero-Sovietic Friendship Hospital, Phnom Penh, Cambodia; Medecins Sans Frontieres, Paris, France
Citation: Trop Med Int Health 2011;16(2):205-13
Journal: Tropical Medicine & International Health : TM & IH
Issue Date: 1-Feb-2011
URI: http://hdl.handle.net/10144/120329
DOI: 10.1111/j.1365-3156.2010.02689.x
PubMed ID: 21087376
Additional Links: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2010.02689.x/abstract
Abstract: Objectives  To report immunovirological outcomes and resistance patterns in adults treated with triple combination antiretroviral therapy (cART) for 4 years in an HIV programme of Phnom Penh, Cambodia. Methods  It is a longitudinal study and cross-sectional evaluation of adults receiving cART for 4 years. CD4 cell counts and HIV-1 RNA were quantified, and resistance patterns were determined. Drug-related toxicity was assessed by clinicians and through laboratory testing. Results  After 4 years of cART start, the cumulative probability of retention in care was 0.80 and survival among patients not lost to follow-up was 0.85. A total of 349 patients (98% of eligible) participated in the cross-sectional evaluation. Ninety per cent were receiving first-line therapy, 29% stavudine- and 58% zidovudine-containing regimens (compared with 94% and 3% at cART initiation). Ninety-three per cent of patients were clinically asymptomatic, and severe lipodystrophy and dyslipidemia were diagnosed in 7.2% and 4.0%, respectively. Good treatment adherence was reported by 83% of patients. Median CD4 T-cell count was 410 cells/μl [IQR 290-511], and 90% of patients had >200 cells/μl. Only 15 (4%) patients had detectable HIV viral load (eight had <200 CD4 cells/μl), five had thymidine analogue mutations, and nine were resistant to two drug classes. In an intention-to-treat analysis, 26.1% (95% CI 22.0-30.5) of patients had failed first-line therapy. Conclusions  In this Cambodian cohort of adults who started cART at an advanced stage of HIV disease, we observed good clinical and immunovirological outcomes and self-reported treatment adherence at 4 years of therapy.
Type: Article
Language: en
MeSH: HIV/AIDS
Antiretroviral Therapy
Cambodia
Drug Resistance
Treatment Outcome
ISSN: 1365-3156
Rights: Archived on this site with the kind permission of Wiley-Blackwell, http://www.blackwell-synergy.com/loi/tmi
Appears in topics: HIV/AIDS

Related articles on PubMed
bullet
Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
Landman R, Damond F, Gerbe J, Brun-Vezinet F, Yeni P, Matheron S
2009 Jan 28
bullet
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK, Panel on Clinical Practices for Treatment of HIV
2002 Sep 3
bullet
bullet
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK, Panel on Clinical Practices for the Treatment of HIV
2002 May 17
bullet
Short communication: three years follow-up of first-line antiretroviral therapy in cambodia: negative impact of prior antiretroviral treatment.
Ségéral O, Limsreng S, Nouhin J, Hak C, Ngin S, De Lavaissière M, Goujard C, Taburet AM, Nerrienet E, Delfraissy JF, Ouk V, Dulioust A
2011 Jun
See all 189 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Jul 23, 2014